ISMP is conducting a short survey on the continuing crisis with drug shortages and supply chain disruptions. Please take a few minutes to complete this survey by July 27, 2023: www.ismp.org/
ext/1195.
We appreciate your participation!

Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, July 27, 2023 from 1:00-2:00 PM ET.
Register Now: https://ecri.zoom.us/webinar/register/WN_XTPKHOqaT2WvxfrXVZdpwg#/registr...

Short medication safety-related presentations for this webinar will include:

• Cyclic parenteral nutrition: A method to support infusion pump integration
Jennifer Williams, PharmD, BCPS
Clinical Pharmacist
Mercy Cedar Rapids

• What is the Prescription for Adherence? The 3 As of workflow
Rachel DiPaolantonio, PharmD
Pharmacist
Weis Markets Pharmacy

• Utilizing the HAMST-R and HAMST-R PRO tools
Joel Daniel, PharmD, MS, CPPS
Medication Safety Supervisor
CoxHealth

• ISMP Update
Rita K. Jew, PharmD, MBA, BCPPS, FASHP
President, ISMP

While REMS programs are intended to mitigate risk, a number of factors can make proper deployment difficult. This week’s ISMP featured newsletter article, part one of a two-part series, highlights some of the REMS-related problems reported to ISMP: https://www.ismp.org/node/87562

ISMP is conducting a short survey to get a sense of the current level of implementation of the 2022-2023 Targeted Medication Safety Best Practices for Hospitals. We would very much appreciate your participation in this survey. Please complete this survey online by June 30, 2023, by visiting: www.ismp.org/ext/1164. The findings will also be described when introducing the new 2024-2025 Targeted Medication Safety Best Practices for Hospitals early in 2024.

The third episode ISMP’s medication safety podcast series focuses on how to reduce the risk of patient harm and medication errors associated with inappropriate polypharmacy. To watch: https://www.ismp.org/events/perils-polypharmacy

This week’s ISMP featured newsletter article provides recommendations for preventing errors when pediatric patients need to be treated in settings that are not designated solely for children: https://www.ismp.org/node/82964

An International Medication Safety Network (IMSN) special interest group chaired by ISMP recently published recommendations for global implementation of safe oxytocin use practices: https://www.intmedsafe.net/imsn-oxytocin-sig-issues-recommendations-for-...

ISMP’s most recent featured newsletter article takes a closer look at oxytocin-related errors, including uncovering some new trends, and provides safe practice recommendations: https://www.ismp.org/node/80423

ISMP’s new online, interactive course offers healthcare organizations a standardized, cost-effective way to ensure staff involved in the medication use process have the basic knowledge they need to avoid risks and prevent errors. It is available through an annual organizational subscription. For more: https://www.ismp.org/educational-services-healthcare-organizations

Respondents to a recent ISMP survey indicated that strategic frameworks like California’s Medication Error Reduction Plan (MERP) can help reduce risk, increase reporting, and justify MSO and similar positions: www.ismp.org/node/75991